Latest filing published 22 Feb 2022 for AMEDISYS INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christopher Gerard: trading record in brief
Christopher Gerard is a declared insider of Amedisys Inc (chief executive), with filings sourced from SEC (Form 4). Between 20 January 2017 and 20 February 2022, the trades on record add up to 139 filings.
The open-market record consists of 107 sales worth €4.3M, with no purchase. Other entries cover 25 share grants and 7 option exercises.
The newest entry dates from 22 February 2022: a share grant of €257k, in Amedisys Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Gerard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,109 shares0Common StockSEC:0000896262-22-000012:0
- 100 shares@ US$257.447.6% of flowCommon StockSEC:0000896262-21-000102:0
- 950 shares@ US$250.7870.5% of flowCommon StockSEC:0000896262-21-000096:0
- 200 shares@ US$254.1014.6% of flowCommon StockSEC:0000896262-21-000076:0
- 100 shares@ US$257.357.4% of flowCommon StockSEC:0000896262-21-000072:0
5 of 5 declarations
